Related Experiment Videos
Osteosarcoma in New Zealand 1981-7: an overview
The New Zealand Medical Journal
|November 10, 1995
Summary
This study on osteosarcoma in New Zealand (1981-1987) found a 29% overall 5-year survival rate, with better outcomes for younger patients and those treated with surgery and chemotherapy.
Area of Science:
- Oncology
- Epidemiology
- Cancer Research
Background:
- Osteosarcoma is a rare bone cancer.
- Understanding its incidence and treatment outcomes is crucial for improving patient care.
Purpose of the Study:
- To investigate the incidence and treatment outcomes of osteosarcoma in New Zealand.
- To analyze survival rates based on patient demographics and treatment modalities.
Main Methods:
- Data collected from the New Zealand Cancer Registry for osteosarcoma cases diagnosed between 1981 and 1987.
- Analysis of 104 patient records.
Main Results:
- Peak incidence observed in the second decade of life, with a smaller peak in older adults.
- Overall 5-year survival rate was 29%.
- Patients under 30 had a 44% 5-year survival, while those over 60 had a 3.2% survival rate. Survival improved with surgery, chemotherapy, and appendicular skeleton tumors.
Conclusions:
- The study highlights a mixed patient group with 5-year survival rates potentially lower than international benchmarks.
- Treatment strategies involving surgery and chemotherapy, and tumor location, significantly impact survival outcomes.